Functional Food Detail
B616
D sleep(ディースリープ)
常盤薬品工業株式会社
販売休止中
加工食品(錠剤、カプセル剤等)
Category
Notif. Date
2017-03-30
Planned Sale Date
Functional Claim
本品にはラフマ由来ヒペロシド及びラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド及びラフマ由来イソクエルシトリンには、睡眠の質(眠りの深さ)の向上に役立つことが報告されています。
Content
Functional Claim
本品にはラフマ由来ヒペロシド及びラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド及びラフマ由来イソクエルシトリンには、睡眠の質(眠りの深さ)の向上に役立つことが報告されています。
AI Summary
Automatically generated from notification documents
This product contains hyperoside and isoquercitrin derived from rhodiola. These ingredients have been reported to support sleep quality, particularly by promoting deeper sleep. It helps maintain daily wellness as a food that supports rest quality.
Key Features
[
"
R
h
o
d
i
o
l
a
-
d
e
r
i
v
e
d
i
n
g
r
e
d
i
e
n
t
s
"
,
"
S
u
p
p
o
r
t
s
s
l
e
e
p
q
u
a
l
i
t
y
"
,
"
P
r
o
m
o
t
e
s
d
e
e
p
e
r
s
l
e
e
p
"
]
For those concerned about their sleep quality.
Notification Documents
Product NameD sleep(ディースリープ)
Category
Food Classification加工食品(錠剤、カプセル剤等)
Functional Ingredient Nameラフマ由来ヒペロシド及びラフマ由来イソクエルシトリン
Functional ingredient is an extractNo
Functional Claim本品にはラフマ由来ヒペロシド及びラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド及びラフマ由来イソクエルシトリンには、睡眠の質(眠りの深さ)の向上に役立つことが報告されています。
Consumer Affairs Department Contact
Information Disclosure Website URL
1. Basic Safety Information
(1) Precautions for Intake
(2) Safety Evaluation Method
(3) Notifier's Safety Evaluation
2. Production, Manufacturing & Quality Control
Details
3. Basic Functionality Information
(1) Functionality Evaluation Method
(2) Notifier's Functionality Evaluation
4. Other Notification Items
Reason for not classifying as tablet/capsule food
Primary Target Audience
Planned Sales Start Date
Change History (before Mar 31, 2025)
Change History (from Apr 1, 2025)
Before/After Comparison Table
Before/After Comparison Table (attachments)
If re-notificationNo
Existing Notification Number
Reason for Maintaining Identity
Post-notification Sales Status販売休止中
Reason for Notification Withdrawal
5. Self-Inspection Report
Month of Last Self-Inspection Report